Katharine Gemmell, Bloomberg , Author at ACTSA

Parasite drug analysed as possible Covid treatment in UK trial

by Katharine Gemmell, Bloomberg | Jun 23, 2021 | Moneyweb

Eligible UK participants with Covid-19 symptoms can join the ivermectin trial, which is being evaluated alongside the influenza antiviral favipiravir.

Facebook’s dating service goes live In Europe after long delay

by Katharine Gemmell, Bloomberg | Oct 22, 2020 | Moneyweb

Despite second-wave of coronavirus in the region.